Abstract
Because of their relatively limited resources for health care, Central and Eastern European (CEE) countries are typically late adopters of new medical devices (MDs). This provides an opportunity to learn from experiences of early technology adopter countries in Western Europe and transfer knowledge about health technology assessment (HTA) and coverage with evidence development (CED) schemes. Implementation of CED schemes is limited in CEE countries, which are usually late adopters of new health technologies.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have